Kast WM - Search Results

1

Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses.

Woodham AW, Cheloha RW, Ling J, Rashidian M, Kolifrath SC, Mesyngier M, Duarte JN, Bader JM, Skeate JG, Da Silva DM, Kast WM, Ploegh HL. Woodham AW, et al. Among authors: kast wm. Cancer Immunol Res. 2018 Jul;6(7):870-880. doi: 10.1158/2326-6066.CIR-17-0661. Epub 2018 May 23. Cancer Immunol Res. 2018. PMID: 29792298 Free PMC article.

2

Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses.

De Bruijn ML, Nieland JD, Schumacher TN, Ploegh HL, Kast WM, Melief CJ. De Bruijn ML, et al. Among authors: kast wm. Eur J Immunol. 1992 Nov;22(11):3013-20. doi: 10.1002/eji.1830221137. Eur J Immunol. 1992. PMID: 1425925

3

Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.

De Bruijn ML, Schumacher TN, Nieland JD, Ploegh HL, Kast WM, Melief CJ. De Bruijn ML, et al. Among authors: kast wm. Eur J Immunol. 1991 Dec;21(12):2963-70. doi: 10.1002/eji.1830211210. Eur J Immunol. 1991. PMID: 1660811

4

Peptide selection by MHC class I molecules.

Schumacher TN, De Bruijn ML, Vernie LN, Kast WM, Melief CJ, Neefjes JJ, Ploegh HL. Schumacher TN, et al. Among authors: kast wm. Nature. 1991 Apr 25;350(6320):703-6. doi: 10.1038/350703a0. Nature. 1991. PMID: 1708852

5

T-cell immunotherapy of cancer.

Melief CJ, Kast WM. Melief CJ, et al. Among authors: kast wm. Res Immunol. 1991 Jun-Aug;142(5-6):425-9. doi: 10.1016/0923-2494(91)90042-h. Res Immunol. 1991. PMID: 1754715 Review.

6

Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.

Schumacher TN, Heemels MT, Neefjes JJ, Kast WM, Melief CJ, Ploegh HL. Schumacher TN, et al. Among authors: kast wm. Cell. 1990 Aug 10;62(3):563-7. doi: 10.1016/0092-8674(90)90020-f. Cell. 1990. PMID: 2199065

7

Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells.

Stam NJ, Kast WM, Voordouw AC, Pastoors LB, van der Hoeven FA, Melief CJ, Ploegh HL. Stam NJ, et al. Among authors: kast wm. J Immunol. 1989 Jun 1;142(11):4113-7. J Immunol. 1989. PMID: 2541206

8

Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2.

Hooijberg E, Sein JJ, van den Berk PC, Hart AA, van der Valk MA, Kast WM, Melief CJ, Hekman A. Hooijberg E, et al. Among authors: kast wm. Cancer Res. 1995 Jun 15;55(12):2627-34. Cancer Res. 1995. PMID: 7540106

9

Cellular immunity and immunotherapy against deoxyribonucleic acid virus-induced tumors.

Macedo MF, Velders MP, Nieland JD, Rudolf MP, Weijzen S, Da Silva DM, Franke A, Holt G, Loviscek K, Carbone M, Kast WM. Macedo MF, et al. Among authors: kast wm. Monaldi Arch Chest Dis. 1998 Apr;53(2):211-8. Monaldi Arch Chest Dis. 1998. PMID: 9689811 Review.

10

Induction of HPV16 capsid protein-specific human T cell responses by virus-like particles.

Rudolf MP, Nieland JD, DaSilva DM, Velders MP, Müller M, Greenstone HL, Schiller JT, Kast WM. Rudolf MP, et al. Among authors: kast wm. Biol Chem. 1999 Mar;380(3):335-40. doi: 10.1515/BC.1999.045. Biol Chem. 1999. PMID: 10223336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters